ANGIOGENESIS INHIBITORS FROM PLANTS ORIGIN: PERSPECTIVE FOR CLINICAL USAGE
At present, screening for agents derived from plants that inhibit tumor angiogenesis becomes one of the promising approaches to treat tumor. The program of plant’ anti-angiogenic activity screening exists in USA, South America and other countries. In this review we discuss the data accumulated of plant origin’ agents with high anti-angiogenic activity.